BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31803613)

  • 1. Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy.
    Veselska R; Jezova M; Kyr M; Mazanek P; Chlapek P; Dobrotkova V; Sterba J
    Front Oncol; 2019; 9():1221. PubMed ID: 31803613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers.
    Dobrotkova V; Chlapek P; Jezova M; Adamkova K; Mazanek P; Sterba J; Veselska R
    PLoS One; 2019; 14(6):e0218269. PubMed ID: 31188873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone demethylase KDM6B has an anti-tumorigenic function in neuroblastoma by promoting differentiation.
    Yang L; Zha Y; Ding J; Ye B; Liu M; Yan C; Dong Z; Cui H; Ding HF
    Oncogenesis; 2019 Jan; 8(1):3. PubMed ID: 30631055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PBX1 is a valuable prognostic biomarker for patients with breast cancer.
    Ao X; Ding W; Ge H; Zhang Y; Ding D; Liu Y
    Exp Ther Med; 2020 Jul; 20(1):385-394. PubMed ID: 32565927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1.
    Xuan F; Huang M; Liu W; Ding H; Yang L; Cui H
    Neuro Oncol; 2016 Jun; 18(6):819-29. PubMed ID: 26582930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer.
    Hu M; Ou-Yang W; Jing D; Chen R
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
    Hong Y; Zhao X; Qin Y; Zhou S; Chang Y; Wang Y; Zhang X; Xu L; Huang X
    Ann Hematol; 2018 Sep; 97(9):1547-1554. PubMed ID: 29705861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols.
    Felice MS; Gallego MS; Alonso CN; Alfaro EM; Guitter MR; Bernasconi AR; Rubio PL; Zubizarreta PA; Rossi JG
    Leuk Lymphoma; 2011 Jul; 52(7):1215-21. PubMed ID: 21534874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
    Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
    Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.
    Haber M; Smith J; Bordow SB; Flemming C; Cohn SL; London WB; Marshall GM; Norris MD
    J Clin Oncol; 2006 Apr; 24(10):1546-53. PubMed ID: 16575006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of DDX39A as a Potential Biomarker for Unfavorable Neuroblastoma Using a Proteomic Approach.
    Otake K; Uchida K; Ide S; Kobayashi Y; Kobayashi I; Kusunoki M
    Pediatr Blood Cancer; 2016 Feb; 63(2):221-7. PubMed ID: 26469522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy.
    Du L; Liu L; Zhang C; Cai W; Wu Y; Wang J; Lv F
    J Pediatr Surg; 2014 Apr; 49(4):528-33. PubMed ID: 24726106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma.
    Takahashi Y; Gleber-Netto FO; Bell D; Roberts D; Xie TX; Abdelmeguid AS; Pickering C; Myers JN; Hanna EY
    Oral Oncol; 2019 Oct; 97():56-61. PubMed ID: 31421472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system.
    Suc A; Lumbroso J; Rubie H; Hattchouel JM; Boneu A; Rodary C; Robert A; Hartmann O
    Cancer; 1996 Feb; 77(4):805-11. PubMed ID: 8616776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.
    Westermann F; Henrich KO; Wei JS; Lutz W; Fischer M; König R; Wiedemeyer R; Ehemann V; Brors B; Ernestus K; Leuschner I; Benner A; Khan J; Schwab M
    Clin Cancer Res; 2007 Aug; 13(16):4695-703. PubMed ID: 17652624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy between loss of NF1 and overexpression of MYCN in neuroblastoma is mediated by the GAP-related domain.
    He S; Mansour MR; Zimmerman MW; Ki DH; Layden HM; Akahane K; Gjini E; de Groh ED; Perez-Atayde AR; Zhu S; Epstein JA; Look AT
    Elife; 2016 Apr; 5():. PubMed ID: 27130733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The leukemogenic transcription factor E2a-Pbx1 induces expression of the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells.
    Rutherford MN; Bayly GR; Matthews BP; Okuda T; Dinjens WM; Kondoh H; LeBrun DP
    Leukemia; 2001 Mar; 15(3):362-70. PubMed ID: 11237058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1.
    Jung JG; Shih IM; Park JT; Gerry E; Kim TH; Ayhan A; Handschuh K; Davidson B; Fader AN; Selleri L; Wang TL
    Cancer Res; 2016 Nov; 76(21):6351-6361. PubMed ID: 27590741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hydrophobic residue in the TALE homeodomain of PBX1 promotes epithelial-to-mesenchymal transition of gastric carcinoma.
    He C; Wang Z; Zhang L; Yang L; Li J; Chen X; Zhang J; Chang Q; Yu Y; Liu B; Zhu Z
    Oncotarget; 2017 Jul; 8(29):46818-46833. PubMed ID: 28514754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of E2a-pbx1 expression level with clinical characteristics and early response to treatment in children with acute lymphoblastic leukemia].
    Gao C; Li ZG; Zhao W; Wu MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):569-73. PubMed ID: 18549631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.